Marie‐Claude Parent
Montreal Heart Institute(CA)Université de Montréal(CA)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Transplantation: Methods and Outcomes, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Cardiac pacing and defibrillation studies
Most-Cited Works
- → CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction(2021)285 cited
- → CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis(2020)120 cited
- → Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis(2020)111 cited
- → Care Gaps in Adherence to Heart Failure Guidelines(2020)100 cited
- → Aortic regurgitation in patients with a left ventricular assist device: A contemporary review(2018)86 cited
- → Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event(2020)80 cited
- → Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.(1995)77 cited
- → Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation(2017)52 cited
- → Barriers to Goals of Care Discussions With Patients Who Have Advanced Heart Failure: Results of a Multicenter Survey of Hospital-Based Cardiology Clinicians(2017)50 cited
- → Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial(2025)38 cited